Diagnosis
·
Laboratory analysis: Samples of serum, stool, vomitus,
gastric contents, and suspected food item should be tested for Cl. botulinum as well as botulinum
toxin. The specimens should be handled cautiously, refriger-ated, and examined
as soon as possible after collection. Stool specimens must be incubated
anaerobically and subcultured on egg yolk agar.
The usual procedure is to draw 10 ml
of serum before treatment has begun, for determination of toxin. The standard
laboratory study is the mouse bioassay. Analysis takes 24 hours to perform, so
the results cannot be used to determine treatment. Mouse bioassay for botulinum
toxins is extremely sensitive and detects as little as 5 to 10 pg toxin/ml.
ELISA tests have not been shown to have the same sensitivity as the mouse
bioassay.
Diagnosis is confirmed by
demonstration of toxin in serum, stool, or food items, or by isolation of
organism in stool or food items.
·
Tensilon test: Tensilon (edrophonium) is a rapid-acting
anticholinesterase used to differentiate botulism from myasthenia gravis. 10 mg
of the drug is injected IV slowly (1 to 2 mg at first, followed by the
remainder over the next 5 minutes). Muscle strength in myasthenia gravis will
improve dramatically within ½ to 1 minute, and last for about 5 minutes, while
there will be little or no improvement in botulism.
·
Electromyography: In all forms of botulism, the EMG pattern
is characterised by brief, small, abundant motor unit action potentials. Motor
nerve conduction velocity is normal. Another characteristic EMG finding is an
increment of small compound muscle action potential amplitude directly related
to the release of acetylcholine following repetitive stimulation at 20–50 Hz.
·
Bedside spirometry to determine forced vital capacity (FVC)
and inspiratory force should be done sequentially in suspected patients. These tests
may provide early clues of impending respiratory failure. Arterial blood gases
may show only minor abnormalities despite substantial loss of ventilatory
reserve.
·
Experimental and clinical evidence suggests that botulinum
toxin may exert a direct cardiac effect.
Intraventricular conduction delay,
non-specific ST-T wave changes, and arrhythmias, including sudden death from
ventricular fibrillation, have all been reported.
·
Laboratory analysis: Wound cultures
and serum assays for botulinum toxin.
·
Tensilon test.
·
Electromyography.
·
History: of honey ingestion.
·
Clinical picture.
·
Tensilon test: unreliable in
infants.
·
Stool analysis.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.